# Veronica Venturelli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/veronica-venturelli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 91 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 5 |
| i10-index | 4 |
| Last Known Institution | University of Ferrara |
| OpenAlex ID | https://openalex.org/A5026463285 |
| ORCID iD | 0000-0003-0681-1472 |
| Works | 11 |

## Researcher papers

- [Prognostic role of the ascending aorta dilatation in patients with arterial hypertension](https://scholariq.org/papers/prognostic-role-of-the-ascending-aorta-dilatation-in-patients-with-arterial/)
- [Can complement activation be the missing link in antiphospholipid syndrome?](https://scholariq.org/papers/can-complement-activation-be-the-missing-link-in-antiphospholipid-syndrome/)
- [The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus](https://scholariq.org/papers/the-impact-of-antiphospholipid-antibodies-antiphospholipid-syndrome-on-systemic/)
- [Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next](https://scholariq.org/papers/targeted-therapy-for-sle-what-works-what-doesn-t-what-s-next/)
- [Where are we now in biologic drugs for myositis?](https://scholariq.org/papers/where-are-we-now-in-biologic-drugs-for-myositis/)
- [Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities](https://scholariq.org/papers/promising-experimental-treatments-for-lupus-nephritis-key-talking-points-and/)
- [Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis](https://scholariq.org/papers/evaluation-of-the-synovial-effects-of-biological-and-targeted-synthetic-dmards/)
- [Complement Activation Is Increased in Antiphospholipid Syndrome-Related Ischemic Stroke with Higher Risk Features](https://scholariq.org/papers/complement-activation-is-increased-in-antiphospholipid-syndrome-related-ischemic/)
- [Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell carcinoma](https://scholariq.org/papers/scleroderma-as-paraneoplastic-disease-a-new-case-of-a-rare-association-with/)
- [Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?](https://scholariq.org/papers/janus-kinase-inhibitors-in-rheumatoid-arthritis-associated-interstitial-lung/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Researcher university

- [University of Ferrara](https://scholariq.org/institutions/university-of-ferrara/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.